Page last updated: 2024-08-24

allicin and angiotensin ii

allicin has been researched along with angiotensin ii in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hu, JJ; Jia, W; Li, CY; Li, XH; Lu, JM; Tian, RB; Xiang, ZG1
Ba, L; Cao, Y; Chen, Y; Dong, C; Gao, J; Guan, X; Pan, H; Qi, H; Shi, P; Song, C; Sun, H; Zhang, Q1

Other Studies

2 other study(ies) available for allicin and angiotensin ii

ArticleYear
Allicin ameliorates cardiac hypertrophy and fibrosis through enhancing of Nrf2 antioxidant signaling pathways.
    Cardiovascular drugs and therapy, 2012, Volume: 26, Issue:6

    Topics: Angiotensin II; Animals; Antioxidants; Collagen; Disulfides; Fibrosis; Glutamate-Cysteine Ligase; Hemodynamics; Hypertrophy, Left Ventricular; Male; NF-E2-Related Factor 2; Organ Size; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; RNA, Messenger; Signal Transduction; Sulfinic Acids

2012
Allicin attenuates pathological cardiac hypertrophy by inhibiting autophagy via activation of PI3K/Akt/mTOR and MAPK/ERK/mTOR signaling pathways.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2019, Volume: 58

    Topics: Angiotensin II; Animals; Autophagy; Cardiomegaly; Cardiotonic Agents; Disulfides; Male; MAP Kinase Signaling System; Myocytes, Cardiac; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats, Wistar; Signal Transduction; Sulfinic Acids; TOR Serine-Threonine Kinases

2019